Position in JNJ
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$432,764
+$28,216 QoQ
Shares Held
1,704
+3.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
2.87%
of 13F equity value
Holder Rank
#3,827
of 4,664 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Beacon Financial Strategies CORP holds $2,982,740 across 9 Drug Manufacturers - General names. JNJ ranks #4 (14.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
801 | $960,743 | |
| 2 | GSK |
GSK plc
|
11,358 | $595,386 | |
| 3 | MRK |
Merck & Co., Inc.
|
3,796 | $487,786 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
1,704 | $432,764 | |
| 5 | ABBV |
AbbVie Inc.
|
791 | $199,047 | |
| 6 | PFE |
Pfizer Inc
|
7,714 | $185,753 | |
| 7 | NVS |
Novartis AG
|
489 | $76,636 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
708 | $40,794 |
All Filings in JNJ
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $432,764 | 1,704 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $404,548 | 1,655 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $342,502 | 1,655 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $306,870 | 1,655 | Shares | Sole | 2025-10-06 | |
| 2025-06-30 | $252,801 | 1,655 | Shares | Sole | 2025-09-25 | |
| 2025-03-31 | $274,465 | 1,655 | Shares | Sole | 2025-09-25 | |
| 2024-12-31 | $203,191 | 1,405 | Shares | Sole | 2025-09-25 | |
| 2024-09-30 | $227,694 | 1,405 | Shares | Sole | 2025-09-25 | |
| 2024-06-30 | $205,354 | 1,405 | Shares | Sole | 2025-09-25 | |
| 2024-03-31 | $247,567 | 1,565 | Shares | Sole | 2025-09-25 | |
| 2023-12-31 | $245,298 | 1,565 | Shares | Sole | 2025-09-25 | |
| 2023-09-30 | $246,085 | 1,580 | Shares | Sole | 2025-09-25 | |
| 2023-06-30 | $272,445 | 1,646 | Shares | Sole | 2025-09-25 | |
| 2023-03-31 | $267,995 | 1,729 | Shares | Sole | 2025-09-25 | |
| 2022-12-31 | $313,377 | 1,774 | Shares | Sole | 2025-09-25 | |
| 2022-09-30 | $297,151 | 1,819 | Shares | Sole | 2025-09-25 | |
| 2022-06-30 | $331,766 | 1,869 | Shares | Sole | 2025-09-25 | |
| 2022-03-31 | $331,242 | 1,869 | Shares | Sole | 2025-09-25 | |
| 2021-12-31 | $338,034 | 1,976 | Shares | Sole | 2025-09-25 | |
| 2021-09-30 | $313,956 | 1,944 | Shares | Sole | 2025-09-25 | |
| 2021-06-30 | $320,254 | 1,944 | Shares | Sole | 2025-09-25 | |
| No filing history on record for this holder in this stock. | ||||||